Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 15, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 August 2026 - 16:02

Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 15, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tezspire

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters